Quantenna Communications (QTNA) Prices 6.7M Common Stock IPO at $16/Share, at Upper-End of Expected Range
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Quantenna Communications, Inc. (Nasdaq: QTNA) announced the pricing of its initial public offering of 6,700,000 shares of its common stock at a price to the public of $16.00 per share. In addition, Quantenna has granted the underwriters a 30-day option to purchase up to an additional 1,005,000 shares of common stock to cover over-allotments, if any. The shares are expected to begin trading on The NASDAQ Global Select Market on October 28, 2016 under the symbol “QTNA.”
(NOTE: The company was recently looking for a pricing range of $14 - $16 per share.)
Morgan Stanley & Co. LLC, Barclays Capital Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. Needham & Company, LLC, William Blair & Company, L.L.C. and Roth Capital Partners, LLC are acting as co-managers for the offering.
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
The offering is being made only by means of a prospectus. Copies of the prospectus related to the offering may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 1-888-603-5847, or by email at Barclaysprospectus@broadridge.com; or Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York NY 10005, by telephone at 1-800-503-4611, or by email at firstname.lastname@example.org.
The Blueshirt Group
Soohwan Kim, CFA
Source: Quantenna Communications
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keane Group (FRAC) IPO Opens Up 16%
- Rite Aid (RAD)/Walgreens (WBA) Antitrust Concerns Doesn't Mean Deal is Dead, Says Deutsche Bank
- Pluristem Therapeutics (PSTI) Increases Bought Deal Offering of Common Stock and Warrants to $15M
Create E-mail Alert Related CategoriesCorporate News, Hot Corp. News, IPOs
Related EntitiesDeutsche Bank, William Blair, Morgan Stanley, Needham & Company, Roth Capital, Barclays, IPO
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!